KR830004256A - 치환된 3,6-비스(아미노알콕시) 아크리딘류의 제조방법 - Google Patents
치환된 3,6-비스(아미노알콕시) 아크리딘류의 제조방법 Download PDFInfo
- Publication number
- KR830004256A KR830004256A KR1019800004119A KR800004119A KR830004256A KR 830004256 A KR830004256 A KR 830004256A KR 1019800004119 A KR1019800004119 A KR 1019800004119A KR 800004119 A KR800004119 A KR 800004119A KR 830004256 A KR830004256 A KR 830004256A
- Authority
- KR
- South Korea
- Prior art keywords
- hydrogen
- aminoalkoxy
- acridines
- bis
- preparing substituted
- Prior art date
Links
- 150000001251 acridines Chemical class 0.000 title 1
- 125000002431 aminoalkoxy group Chemical group 0.000 title 1
- 239000001257 hydrogen Substances 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- -1 Pyrrolidino, piperidino, morpholino Chemical group 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- XTXCACFBMYGMCO-UHFFFAOYSA-N [Na].[Na].Oc1ccc2cc3ccc(O)cc3nc2c1 Chemical class [Na].[Na].Oc1ccc2cc3ccc(O)cc3nc2c1 XTXCACFBMYGMCO-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000005494 condensation Effects 0.000 claims 1
- 238000009833 condensation Methods 0.000 claims 1
- 150000004696 coordination complex Chemical class 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (1)
- 하기구조식(Ⅱ)의 치환된 3,6-아크리딘디올디나트륨염을 2몰당량의 하기구조식(Ⅲ)의 알킬 할라이드와, 75°-100℃의 불활성용매내에서 응축이 실질적으로 일어나기에 충분한 시간동안 응축시키고: 원한다면 그의 금속복합체 또는 산부가염을 형성하는 것을 특징으로 하는 하기구조식(Ⅰ)의 제조방법.여기서 n은 1,2 또는 3 : R1및 R2는 각각 수소 또는 메틸 : R3및 R4는 같거나 다르고 수소 또는 C1-C4의 직쇄나 분지된 알킬 : 그리고 R3및 R4는 인접한 N(질소)과 함께 피롤리디노, 피페리디노, 모르폴리노 또는 N-메틸피페라지노; 그리고 R5, R6및 R7은 같거나 다르고 수소, 플로로, 클로로, 브로모 및 니트로이다 : 단 n이 1 또는 2이고 R1과 R2가 수소 또는 메틸이고 R3및 R4가 저급알킬일때는 R5, R6및 R7중 적어도 하나는 수소이 외의 치환체이어야 한다. X는 클로로 또는 브로모이다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8980579A | 1979-10-31 | 1979-10-31 | |
US89805 | 1998-06-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR830004256A true KR830004256A (ko) | 1983-07-09 |
KR840002088B1 KR840002088B1 (ko) | 1984-11-14 |
Family
ID=22219661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019800004119A KR840002088B1 (ko) | 1979-10-31 | 1980-10-28 | 치환된 3, 6-비스(아미노 알콕시) 아크리딘류의 제조방법 |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0031407B1 (ko) |
JP (1) | JPS5673065A (ko) |
KR (1) | KR840002088B1 (ko) |
AT (1) | ATE26708T1 (ko) |
AU (1) | AU538477B2 (ko) |
CA (1) | CA1170260A (ko) |
DE (1) | DE3071953D1 (ko) |
DK (2) | DK460180A (ko) |
ES (1) | ES8106893A1 (ko) |
HK (1) | HK4491A (ko) |
IE (1) | IE52711B1 (ko) |
ZA (1) | ZA806195B (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3582860D1 (de) * | 1984-11-09 | 1991-06-20 | American Cyanamid Co | 3,6 bis(substituierte) acridinderivate. |
JPH0263325U (ko) * | 1988-10-31 | 1990-05-11 | ||
JPH0740447U (ja) * | 1991-12-04 | 1995-07-18 | 天龍化学工業株式会社 | 箱形容器における注出口装置 |
US9139592B2 (en) | 2010-06-14 | 2015-09-22 | Trt Pharma Inc. | Modulators of Nrf2 and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1727480A (en) * | 1926-07-08 | 1929-09-10 | Winthrop Chem Co Inc | New dialkylamino-alkyl derivatives of the 3.6-dihydroxyacridine |
DE490418C (de) * | 1926-07-09 | 1930-02-05 | I G Farbenindustrie Akt Ges | Verfahren zur Darstellung von basischen AEthern der Acridinreihe |
US3740403A (en) * | 1971-11-05 | 1973-06-19 | American Cyanamid Co | 3,6-bis-(dialkylaminoalkoxy)acridines |
EP0012139A1 (en) * | 1978-12-14 | 1980-06-25 | American Cyanamid Company | Therapeutic agent for stimulating the immune response in a mammal |
-
1980
- 1980-10-03 IE IE2066/80A patent/IE52711B1/en not_active IP Right Cessation
- 1980-10-06 AT AT80106044T patent/ATE26708T1/de not_active IP Right Cessation
- 1980-10-06 EP EP80106044A patent/EP0031407B1/en not_active Expired
- 1980-10-06 DE DE8080106044T patent/DE3071953D1/de not_active Expired
- 1980-10-07 ZA ZA00806195A patent/ZA806195B/xx unknown
- 1980-10-10 AU AU63141/80A patent/AU538477B2/en not_active Ceased
- 1980-10-23 CA CA000363073A patent/CA1170260A/en not_active Expired
- 1980-10-28 KR KR1019800004119A patent/KR840002088B1/ko active
- 1980-10-30 DK DK460180A patent/DK460180A/da unknown
- 1980-10-30 JP JP15150480A patent/JPS5673065A/ja active Granted
- 1980-10-30 DK DK460080A patent/DK460080A/da not_active Application Discontinuation
- 1980-10-30 ES ES496412A patent/ES8106893A1/es not_active Expired
-
1991
- 1991-01-10 HK HK44/91A patent/HK4491A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA1170260A (en) | 1984-07-03 |
AU6314180A (en) | 1981-05-07 |
EP0031407A1 (en) | 1981-07-08 |
HK4491A (en) | 1991-01-18 |
IE802066L (en) | 1981-04-30 |
EP0031407B1 (en) | 1987-04-22 |
DK460180A (da) | 1981-05-01 |
DK460080A (da) | 1981-05-01 |
DE3071953D1 (en) | 1987-05-27 |
AU538477B2 (en) | 1984-08-16 |
JPH0259125B2 (ko) | 1990-12-11 |
KR840002088B1 (ko) | 1984-11-14 |
ES496412A0 (es) | 1981-10-01 |
JPS5673065A (en) | 1981-06-17 |
ATE26708T1 (de) | 1987-05-15 |
ES8106893A1 (es) | 1981-10-01 |
ZA806195B (en) | 1982-05-26 |
IE52711B1 (en) | 1988-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR860004060A (ko) | 티에닐 축합 피라졸 유도체의 제조방법 | |
KR830003528A (ko) | 섬유형성 코폴리에스테르 | |
KR840004106A (ko) | 4급 6,11-디하이드로-디벤조-[b,e]-티에핀-11-N-알킬-노르스코핀 에테르의 제조방법 | |
KR830005148A (ko) | 항 알러지성 이미도디설파마이드의 제조방법 | |
KR880009982A (ko) | 백금착물 | |
KR830004256A (ko) | 치환된 3,6-비스(아미노알콕시) 아크리딘류의 제조방법 | |
GB1398993A (en) | Triazolyl-styryl compounds | |
ES2000061A6 (es) | Procedimiento para la preparacion de esteres de hidroxiacidos dicarboxilicos | |
KR830004320A (ko) | 퀴나졸린 유도체의 제조방법 | |
KR830004210A (ko) | 2-아미노-3-벤조일-페닐아세트아미드 및 환상 동족체 | |
KR850002460A (ko) | 카르바메이트 화합물의 제조방법 | |
KR850008159A (ko) | 2-페닐-4,5,6,7-테트라히드로-2h-인다졸류의 제조방법 | |
KR850004470A (ko) | 유기 화합물의 제조방법 | |
KR840006238A (ko) | 신규 α-아릴-α-피리딜알카노인산 유도체의 제조방법 | |
KR830006176A (ko) | 치환된 펜옥시-아미노프로판올 유도체의 제조방법 | |
KR850002979A (ko) | 1,2,3-트리티안화합물의 신규 제조방법 | |
KR920012309A (ko) | 트리페닐메탄 염료의 제조방법 | |
KR860001815A (ko) | 옥타하이드로-옥사졸로[4,5-g]퀴놀린의 제조방법 | |
KR870003093A (ko) | 퀴놀론카복실산 유도체의 제조방법 | |
KR860002486A (ko) | 티아진포스폰산 유도체의 제조방법 | |
KR840000496A (ko) | 요소유도체 및 그 제조방법 | |
KR830002718A (ko) | 피라졸 유도체의 제조법 | |
KR840001150A (ko) | 치환페닐(티오노)카바메이트의 제조방법 | |
KR840000467A (ko) | 살리칠산 유도체의 제법 | |
KR840002369A (ko) | 1-(3,4,5-트리메톡시신나모일)-4-아미노카르보닐에틸 치환 피페라진 유도체 및 그 제법 |